Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Drugs|August 25, 2011
Acute myeloid leukaemia: optimal management and recent developmentsLuis Villela, Javier Bolaños-Meade
Anti-Cancer Drugs|September 4, 2008
Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphomaLuis Villela, Mauricio García, Rocío Caballero, et al.
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
A PER3 polymorphism is associated with better overall survival in diffuse large B-cell lymphoma in Mexican populationMiguel A Gutiérrez-Monreal, Luis Villela, Severiano Baltazar, et al.
Salud Publica De Mexico|January 22, 2015
[A decade of lead monitoring in schoolchildren in the metropolitan area of Monterrey NL, Mexico]Jesús Santos-Guzmán, Claudia Madrigal-Ávila, José Ascención Hernández-Hernández, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|December 25, 2022
Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphomaCristian Aguilar, Brady E Beltran, Domingo Morales, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 8, 2018
Cytotoxic Activity of a Black Bean (Phaseolus vulgaris L.) Extract and its Flavonoid Fraction in Both In Vitro and In Vivo Models of LymphomaUlises Aregueta-Robles, Oscar R Fajardo-Ramírez, Luis Villela, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot studyVíctor Arízaga-Ballesteros, Mario René Alcorta-García, Lizzeth Carolina Lázaro-Martínez, et al.
Seminars in Arthritis and Rheumatism|September 8, 2021
Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic reviewJulián M Cota-Arce, Jonhatan Cota, Marco A De León-Nava, et al.
Pageof 3